Literature DB >> 16194

Fetal fuels. I. Utilization of ketones by isolated tissues at various stages of maturation and maternal nutrition during late gestation.

G E Shambaugh, S C Mrozak, N Freinkel.   

Abstract

The availability and utilization of B-hydroxybutyrate as an alternate oxidative fuel during fasting hypoglycemia has been examined in the rat conceptus at 18 and 20 days gestation. A 48-hr maternal fast between days 16 and 18 or 18 and 20 resulted in a 50% fall in fetal glucose levels and a marked rise in B-hydroxybutyrate, i.e., 30-fold at 18 and 60-fold at 20 days. Tissue concentrations of B-hydroxybutyrate or acetoacetate did not exceed extracellular levels. Placenta, fetal brain, carcass, and liver all oxidized 14C-labeled B-hydroxybutyrate to 14CO2 when incubated in vitro in the presence of B-hydroxybutyrate. Highest rates of oxidation were apparent in the placenta, followed by brain, liver, and carcass. The D isomer of B-hydroxybutyrate appeared to be oxidized preferentially by all tissues studied. Despite levels of 3-ketoacid CoA transferase and acetoacetyl CoA thiolase lower at 18 than at 20 days, rates of oxidation in individual tissues incubated under identical concentrations of substrate were similar at both times. In liver and brain, increasing rates of 14CO2 generation proportionate to graded concentrations of B-hydroxybutyrate in vitro indicated that such rates were probably determined by substrate availability. B-hydroxybutyrate oxidation in extrahepatic fetal tissues was unaffected by maternal fasting. By contrast, fetal liver derived from fasted mothers generated significantly less 14CO2 from B-hydroxybutyrate than livers from fed mothers. It has been suggested that capabilities for ketone utilization are widespread in tissues of the conceptus, and that such utilization may fulfill in part the oxidative demands for continued anabolic growth during fasting hypoglycemia in the mother.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 16194     DOI: 10.1016/0026-0495(77)90084-1

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  7 in total

1.  Retardation of fetal brain cell growth during maternal starvation: circulating factors versus altered cellular response.

Authors:  D S Gu; G E Shambaugh; B E Metzger; T G Unterman; J A Radosevich
Journal:  Neurochem Res       Date:  1992-06       Impact factor: 3.996

Review 2.  Cerebral metabolic adaptation and ketone metabolism after brain injury.

Authors:  Mayumi L Prins
Journal:  J Cereb Blood Flow Metab       Date:  2007-08-08       Impact factor: 6.200

3.  The maximal activity of phosphate-dependent glutaminase and glutamine metabolism in late-pregnant and peak-lactating rats.

Authors:  M S Ardawi
Journal:  Biochem J       Date:  1987-02-15       Impact factor: 3.857

4.  Hepatic hexokinase domain containing 1 (HKDC1) improves whole body glucose tolerance and insulin sensitivity in pregnant mice.

Authors:  Md Wasim Khan; Medha Priyadarshini; Jose Cordoba-Chacon; Thomas C Becker; Brian T Layden
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-12-10       Impact factor: 5.187

Review 5.  Edited magnetic resonance spectroscopy in the neonatal brain.

Authors:  Yulu Song; Peter J Lally; Maria Yanez Lopez; Georg Oeltzschner; Mary Beth Nebel; Borjan Gagoski; Steven Kecskemeti; Steve C N Hui; Helge J Zöllner; Deepika Shukla; Tomoki Arichi; Enrico De Vita; Vivek Yedavalli; Sudhin Thayyil; Daniele Fallin; Douglas C Dean; P Ellen Grant; Jessica L Wisnowski; Richard A E Edden
Journal:  Neuroradiology       Date:  2021-10-15       Impact factor: 2.995

6.  Glucose homeostasis during the perinatal period in normal rats and rats with a glycogen storage disorder.

Authors:  K R Gain; R Malthus; C Watts
Journal:  J Clin Invest       Date:  1981-05       Impact factor: 14.808

7.  Insulin-like growth factors and binding proteins in the fetal rat: alterations during maternal starvation and effects in fetal brain cell culture.

Authors:  G E Shambaugh; J A Radosevich; R P Glick; D S Gu; B E Metzger; T G Unterman
Journal:  Neurochem Res       Date:  1993-06       Impact factor: 3.996

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.